Premium
F3‐01‐03: Disclosure of amyloid status in secondary prevention trials for Alzheimer's disease
Author(s) -
Sperling Reisa,
Roberts Scott
Publication year - 2012
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2012.05.2120
Subject(s) - biomarker , asymptomatic , medicine , disease , amyloid (mycology) , dementia , clinical trial , oncology , cognitive decline , alzheimer's disease , pathology , biology , biochemistry